Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshiyuki Iwata

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Respirology Case Reports|July 28, 2025
A Case of Nontuberculous Mycobacterial Pulmonary Disease Complicating Massive Pulmonary EmbolismYasuyuki Hayashi, Akihiko Sokai, Toshiyuki Iwata, et al.
Respirology Case Reports|November 2, 2022
Negative pressure pulmonary edema in a patient with COVID-19Satoshi Ikeo, Toshiyuki Iwata, Naoaki Yasuda, et al.
Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|December 10, 2009
[Small cell lung cancer complicated by opsoclonus myoclonus syndrome]Toshiyuki Iwata, Ichiro Yokomura, Shuji Ohsugi, et al.
Thoracic Cancer|February 22, 2023
Transient asymptomatic pulmonary opacities in a patient with MET exon 14 skipping non-small cell lung cancer: A case reportSatoshi Ikeo, Naoaki Yasuda, Yuki Sakai, et al.
Respirology Case Reports|November 28, 2022
Epipericardial fat necrosis in a patient with sudden chest painSatoshi Ikeo, Naoaki Yasuda, Yuki Sakai, et al.
Respirology Case Reports|April 21, 2023
Physiologic <sup>18</sup>F-FDG muscle uptake in severe COPD: Implications for accurate lung cancer stagingYuma Yoshida, Satoshi Ikeo, Naoaki Yasuda, et al.
Respiratory Medicine Case Reports|September 10, 2024
Unilateral acute respiratory distress syndrome appearing contralateral to lung cancerAkihiko Sokai, Toshiyuki Iwata, Satoshi Ikeo, et al.
Respiratory Investigation|November 26, 2024
Persistent COVID-19 improved with immunoglobulin replacement therapy in Good's syndromeIkumi Kashiwagi, Miki Tasato, Akihiko Sokai, et al.
Chemotherapy|July 19, 2014
Phase II study of pemetrexed and erlotinib in pretreated nonsquamous, non-small-cell lung cancer patients without an EGFR mutationYoung Hak Kim, Takashi Nishimura, Hiroaki Ozasa, et al.
Oxford Medical Case Reports|December 25, 2023
Concurrent trastuzumab deruxtecan-induced interstitial lung disease and COVID-19 in the treatment of advanced breast cancerNaoaki Yasuda, Satoshi Ikeo, Akihiko Sokai, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Respirology Case Reports|July 28, 2025
A Case of Nontuberculous Mycobacterial Pulmonary Disease Complicating Massive Pulmonary EmbolismYasuyuki Hayashi, Akihiko Sokai, Toshiyuki Iwata, et al.
Respirology Case Reports|November 2, 2022
Negative pressure pulmonary edema in a patient with COVID-19Satoshi Ikeo, Toshiyuki Iwata, Naoaki Yasuda, et al.
Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|December 10, 2009
[Small cell lung cancer complicated by opsoclonus myoclonus syndrome]Toshiyuki Iwata, Ichiro Yokomura, Shuji Ohsugi, et al.
Thoracic Cancer|February 22, 2023
Transient asymptomatic pulmonary opacities in a patient with MET exon 14 skipping non-small cell lung cancer: A case reportSatoshi Ikeo, Naoaki Yasuda, Yuki Sakai, et al.
Respirology Case Reports|November 28, 2022
Epipericardial fat necrosis in a patient with sudden chest painSatoshi Ikeo, Naoaki Yasuda, Yuki Sakai, et al.
Respirology Case Reports|April 21, 2023
Physiologic <sup>18</sup>F-FDG muscle uptake in severe COPD: Implications for accurate lung cancer stagingYuma Yoshida, Satoshi Ikeo, Naoaki Yasuda, et al.
Respiratory Medicine Case Reports|September 10, 2024
Unilateral acute respiratory distress syndrome appearing contralateral to lung cancerAkihiko Sokai, Toshiyuki Iwata, Satoshi Ikeo, et al.
Respiratory Investigation|November 26, 2024
Persistent COVID-19 improved with immunoglobulin replacement therapy in Good's syndromeIkumi Kashiwagi, Miki Tasato, Akihiko Sokai, et al.
Chemotherapy|July 19, 2014
Phase II study of pemetrexed and erlotinib in pretreated nonsquamous, non-small-cell lung cancer patients without an EGFR mutationYoung Hak Kim, Takashi Nishimura, Hiroaki Ozasa, et al.
Oxford Medical Case Reports|December 25, 2023
Concurrent trastuzumab deruxtecan-induced interstitial lung disease and COVID-19 in the treatment of advanced breast cancerNaoaki Yasuda, Satoshi Ikeo, Akihiko Sokai, et al.
Pageof 4